首页524663 • BOM
add
Bharat Immunologicals&Biologcls Corp Ltd
市场资讯
财务信息
损益表
收入
净收入
| (INR) | 2023info | 年同比变化 |
|---|---|---|
收入 | 4.46亿 | -43.09% |
经营支出 | 2.15亿 | -9.26% |
净收入 | -1.66亿 | -90.08% |
净利润率 | -37.30 | -233.93% |
每股收益 | — | — |
息税折旧摊销前利润 | -1.59亿 | -220.19% |
有效税率 | 25.28% | — |
资产负债表
总资产
负债总额
| (INR) | 2023info | 年同比变化 |
|---|---|---|
现金及短期投资 | 1285.90万 | -72.30% |
总资产 | 18.86亿 | -11.32% |
负债总额 | 10.04亿 | -6.47% |
权益总额 | 8.82亿 | — |
发行在外的股份 | 4318.00万 | — |
市净率 | 0.70 | — |
资产回报率 | -5.00% | — |
资本回报率 | -5.87% | — |
现金流
现金净变动
| (INR) | 2023info | 年同比变化 |
|---|---|---|
净收入 | -1.66亿 | -90.08% |
来自运营的现金 | 1.09亿 | 125.86% |
投资现金 | 462.20万 | -12.99% |
融资现金 | -1.47亿 | -132.69% |
现金净变动 | -3357.20万 | -198.28% |
自由现金流 | 1.25亿 | 126.27% |
简介
Bharat Immunologicals and Biologicals Corporation Limited is a Public Sector Undertaking of the Government of India. Established in 1989 in Bulandshahar, Uttar Pradesh, BIBCOL manufactures oral polio vaccines and other immunisers. The company formulates over 12.5 crore doses of OPV and had aggregated revenues of ₹30.5 crore in fiscal 2006.
BIBCOL is under the administrative control of the Department of Biotechnology, Ministry of Science and Technology. Wikipedia
成立时间
1989
